Skip to content

Time-in-Range–Based Glycemic Management Study

An open, parallel, population-level, randomized controlled, and effective intervention study on the hierarchical management of rural diabetic patients in China for early warning of blood glucose fluctuation characteristics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129429
Enrollment
Unknown
Registered
2026-08-04
Start date
2026-08-31
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Intervention group:Conventional interventions are administered based on the Chinese Diabetes Prevention and Treatment Guidelines (2024 Edition), with blood glucose management via home blood glucose se
Control group:Conventional interventions are administered per the Chinese Guidelines for the Prevention and Treatment of Diabetes (2024 Edition).

Sponsors

Xi'an Jiaotong University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age >=18 years; 2.Glycated hemoglobin (HbA1c) >=7.0%; 3.Having lived locally for at least 6 months and having no plans to relocate within the next year; 4.Voluntary participation in the study and provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1.Age >=80 years; 2.A history of myocardial infarction, stroke, heart failure, or severe arrhythmia, or previous percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG); 3.Severe diseases such as cancer or severe hepatic or renal dysfunction; 4.Pregnancy or breastfeeding, or planning to become pregnant within 12 months; 5.Cognitive impairment, communication difficulties, or limited mobility; 6.Considered unsuitable for participation in the study by an expert or physician;

Design outcomes

Primary

MeasureTime frame
Proportion of participants achieving glycemic control at 6 months (glycated hemoglobin [HbA1c] <7.0%);

Secondary

MeasureTime frame
Mean glycated hemoglobin (HbA1c) at 6 months;Proportion of participants with good medication adherence at 6 months;Diabetes treatment rate at 6 months;Mean fasting blood glucose at 6 months;Glycemic control rate at 3 months (HbA1c <7.0%);

Countries

China

Contacts

Public ContactLi Yuehua

Xi'an Jiaotong University Second Affiliated Hospital

liyuehua@xjtu.edu.cn+86 29 87679386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026